The store will not work correctly when cookies are disabled.
(R)-2-(((1-ethyl-2-oxopiperidin-3-yl)methylamino)methyl)isonicotinic acid
ID: ALA3785378
PubChem CID: 118420859
Max Phase: Preclinical
Molecular Formula: C15H21N3O3
Molecular Weight: 291.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1CCC[C@H](CNCc2cc(C(=O)O)ccn2)C1=O
Standard InChI: InChI=1S/C15H21N3O3/c1-2-18-7-3-4-12(14(18)19)9-16-10-13-8-11(15(20)21)5-6-17-13/h5-6,8,12,16H,2-4,7,9-10H2,1H3,(H,20,21)/t12-/m1/s1
Standard InChI Key: SESICOAOPDFZFN-GFCCVEGCSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 -3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0351 -3.6026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0432 -3.5993 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4990 0.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4939 -0.7591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7903 -1.5136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0919 -0.7681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0971 0.7319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.8007 1.4864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8049 2.6864 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.4010 1.4751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.4373 0.8700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
4 8 1 0
8 9 1 0
7 10 1 0
7 11 2 0
9 12 1 0
13 12 1 1
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
17 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 291.35 | Molecular Weight (Monoisotopic): 291.1583 | AlogP: 1.13 | #Rotatable Bonds: 6 |
Polar Surface Area: 82.53 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.41 | CX Basic pKa: 8.18 | CX LogP: -2.19 | CX LogD: -2.25 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.82 | Np Likeness Score: -0.61 |
References
1. McAllister TE, England KS, Hopkinson RJ, Brennan PE, Kawamura A, Schofield CJ.. (2016) Recent Progress in Histone Demethylase Inhibitors., 59 (4): [PMID:26710088] [10.1021/acs.jmedchem.5b01758] |